Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium.
暂无分享,去创建一个
[1] C. Nanni,et al. Myocardial SPECT: what do we gain from attenuation correction (and when)? , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[2] R. Dannals,et al. Radiosynthesis of 3-[18F]fluoropropyl and 4-[ 18F]fluorobenzyl triarylphosphonium ions , 2004 .
[3] M. D. Di Carli,et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. , 2003, Journal of the American College of Cardiology.
[4] A. Yıldız,et al. The effects of solid food in prevention of intestinal activity in Tc-99m tetrofosmin myocardial perfusion scintigraphy , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[5] A. Sinusas,et al. Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: Technical, physiologic, and clinical issues , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[6] R. Winslow,et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.
[7] M. Murphy,et al. Selective targeting of bioactive compounds to mitochondria. , 1997, Trends in biotechnology.
[8] J. Taki,et al. Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection. , 1996, American heart journal.
[9] R. Hendel,et al. Myocardial Perfusion Imaging With 99mTc Tetrofosmin : Comparison to 201Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial , 1995 .
[10] L. Becker,et al. Myocardial perfusion with [11C]methyl triphenyl phosphonium: measurements of the extraction fraction and myocardial uptake. , 1994, Journal of nuclear biology and medicine.
[11] O Muzik,et al. Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography , 1994, Circulation.
[12] A. Sinusas,et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] P. Slomka,et al. Investigation of Measures to Reduce Interfering Abdominal Activity on Rest Myocardial Images With Tc-99m Sestamibi , 1993, Clinical nuclear medicine.
[14] N. Shuke,et al. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] L. Shaw,et al. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. , 1992, The American journal of cardiology.
[16] M. Verani,et al. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. , 1991, Journal of the American College of Cardiology.
[17] M E Phelps,et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.
[18] R. Okada,et al. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. , 1988, Circulation.
[19] D. Kuhl,et al. N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.
[20] E A Liberman,et al. Conversion of biomembrane-produced energy into electric form. I. Submitochondrial particles. , 1970, Biochimica et biophysica acta.
[21] Josef Machac,et al. Cardiac positron emission tomography imaging. , 2005, Seminars in nuclear medicine.
[22] S. Bergmann,et al. Myocardial perfusion imaging agents: SPECT and PET , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[23] D. Kass,et al. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. , 1999, Circulation research.
[24] P Suetens,et al. A study of the liver-heart artifact in emission tomography. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] R. Hendel,et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. , 1995, Circulation.
[26] F. Smith,et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.